CFM
DNA icon

Catalyst Funds Management’s Ginkgo Bioworks DNA Stock Holding History

Catalyst Funds Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,146
Closed -$57.8K – 511
2025
Q1 		$57.8K Buy
+10,146
New +$103K 0.02% 408
2024
Q3 		– Sell
-300
Closed -$4.01K – 1376
2024
Q2 		$4.01K Buy
+300
New +$8.95K ﹤0.01% 1081

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Catalyst Funds Management's DNA Position: Q2 2025 in Review

Catalyst Funds Management sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 10,146 shares — an estimated $57.8K sold.

Catalyst Funds Management first reported a position in DNA in Q2 2024 and held it in 2 quarters. The position peaked at $57.8K in Q1 2025. 166 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

  • Catalyst Funds Management reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 10,146 Ginkgo Bioworks shares in Q2 2025, an estimated $57.8K.
  • Catalyst Funds Management first reported a position in Ginkgo Bioworks in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Ginkgo Bioworks position peaked at $57.8K in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.